Gotowa bibliografia na temat „MCP-Counter”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „MCP-Counter”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "MCP-Counter"
Inami, K. "MCP-PMT development for Belle-II TOP counter". Physics Procedia 37 (2012): 683–90. http://dx.doi.org/10.1016/j.phpro.2012.02.417.
Pełny tekst źródłaInami, K., N. Kishimoto, Y. Enari, M. Nagamine i T. Ohshima. "A 5 ps TOF-counter with an MCP–PMT". Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 560, nr 2 (maj 2006): 303–8. http://dx.doi.org/10.1016/j.nima.2006.01.027.
Pełny tekst źródłaJung, Seok-Kyu, i Jung-Myung Lee. "(32) Effects of 1-MCP Treatments on Several Major Apple Cultivars Grown in Korea". HortScience 40, nr 4 (lipiec 2005): 1004D—1004. http://dx.doi.org/10.21273/hortsci.40.4.1004d.
Pełny tekst źródłaGruss, H. J., M. A. Brach, R. R. Schumann i F. Herrmann. "Regulation of MCP-1/JE gene expression during monocytic differentiation." Journal of Immunology 153, nr 11 (1.12.1994): 4907–14. http://dx.doi.org/10.4049/jimmunol.153.11.4907.
Pełny tekst źródłaCalvi, M., S. Capelli, P. Carniti, C. Gotti i G. Pessina. "Single photon counting performance of the Auratek-Square MCP-PMT". Journal of Instrumentation 17, nr 11 (1.11.2022): P11009. http://dx.doi.org/10.1088/1748-0221/17/11/p11009.
Pełny tekst źródłaWierzbicki, Jarosław, Artur Lipiński, Iwona Bednarz-Misa, Łukasz Lewandowski, Katarzyna Neubauer, Paulina Lewandowska i Małgorzata Krzystek-Korpacka. "Monocyte Chemotactic Proteins (MCP) in Colorectal Adenomas Are Differently Expressed at the Transcriptional and Protein Levels: Implications for Colorectal Cancer Prevention". Journal of Clinical Medicine 10, nr 23 (26.11.2021): 5559. http://dx.doi.org/10.3390/jcm10235559.
Pełny tekst źródłaNagaraju, Raju, Apurva Kumar R. Joshi, Sowmya Giriyapura Vamadeva i Rajini Padmanabhan Sharda. "Plasma paraoxonase1 activity in rats treated with monocrotophos: a study of the effect of duration of exposure". Interdisciplinary Toxicology 12, nr 3 (1.11.2019): 129–35. http://dx.doi.org/10.2478/intox-2019-0015.
Pełny tekst źródłaAkiyoshi, Takashi, Zhe Wang, Tomoko Kaneyasu, Osamu Gotoh, Norio Tanaka, Sayuri Amino, Noriko Yamamoto i in. "Transcriptomic Analyses of Pretreatment Tumor Biopsy Samples, Response to Neoadjuvant Chemoradiotherapy, and Survival in Patients With Advanced Rectal Cancer". JAMA Network Open 6, nr 1 (20.01.2023): e2252140. http://dx.doi.org/10.1001/jamanetworkopen.2022.52140.
Pełny tekst źródłaMatsuoka, K. "Development and production of the MCP-PMT for the Belle II TOP counter". Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 766 (grudzień 2014): 148–51. http://dx.doi.org/10.1016/j.nima.2014.05.003.
Pełny tekst źródłaWhite, Kieron, Maxime Meylan, Antoine Bougoüin, Kate Connor, Manuela Salvucci, Franck Bielle, Jochen H. M. Prehn i in. "TAMI-51. IDENTIFYING NEW TUMOR MICROENVIRONMENT (TME) CONTEXTS OF VULNERABILITY IN GLIOBLASTOMA". Neuro-Oncology 22, Supplement_2 (listopad 2020): ii224. http://dx.doi.org/10.1093/neuonc/noaa215.938.
Pełny tekst źródłaRozprawy doktorskie na temat "MCP-Counter"
De, Vries-Brilland Manon. "Caractérisation du microenvironnement immunitaire des carcinomes papillaires du rein". Electronic Thesis or Diss., Angers, 2023. http://www.theses.fr/2023ANGE0017.
Pełny tekst źródłaArticle 1: Checkpoint inhibitors in metastatic papillary renal cell carcinoma : papillary Renal Cell Carcinoma (pRCC) is the most common non-clear cell RCC (nccRCC) and a distinct entity, although heterogenous, associated with poor outcomes. The treatment landscape of metastatic pRCC (mpRCC) relied so far on targeted therapies, mimicking previous developments in metastatic clear-cell renal cell carcinoma. However, antiangiogenics as well as mTOR inhibitors retain only limited activity in mpRCC. As development of immune checkpoint inhibitors (ICI) is now underway in patients with mpRCC, we aimed at discussing early activity data and potential for future therapeutic strategies in monotherapy or combination. Expression of immune checkpoints such as PD-L1 and infiltrative immune cells in pRCC could provide insights into their potential immunogenicity, although this is currently poorly described. Based on retrospective and prospective data, efficacy of ICI as single agent remains limited. Combinations with tyrosine-kinase inhibitors, notably with anti-MET inhibitors, harbor promising response rates and may enter the standard of care in untreated patients. Collaborative work is needed to refine the molecular and immune landscape of pRCC, and pursue efforts to set up predictive biomarker-driven clinical trials in these rare tumors. Article 2 : Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Background : papillary Renal CellCarcinoma (pRCC) is the most common non-clear cell RCC (nccRCC), and associated with poor outcomes in the metastatic setting. In this study, we aimed to comprehensively evaluate the immune tumor microenvironment (TME) ,largely unknown, of patients with metastatic pRCC and identify potential therapeutic targets. Methods : we performed quantitative gene expression analysis of TME using MCP-counter methodology, on 2 independent cohorts of localized pRCC (n=271 and n=98). We then characterized the TME, using immunohistochemistry (n=38) and RNA-sequencing (RNA-seq) (n=30) on metastatic pRCC from the prospective AXIPAP trial cohort. Results: unsupervised clustering identified 2 "TME subtypes", in each of the cohorts : the “immune-enriched” and the “immune-low”.Within AXIPAP trial cohort, the “immune-enriched” cluster was significantly associated with a worse prognosis according to the median overall survival to 8 months (95%CI, 6-29) versus 37 months (95%CI, 20-NA,p=0.001).The 2 immune signatures, Teff and JAVELIN Renal 101 Immuno signature, predictive of response to immune checkpoint inhibitors (CPI) in ccRCC, were significantly higher in the “immune-enriched” group (adjusted p<0.05). Finally, 5 differentially overexpressed genes were identified, corresponding mainly to B lymphocyte populations. Conclusion : for the first time, using RNA-seqand IHC, we have highlighted a specific immune TME subtype of metastatic pRCC, significantly more infiltrated with T and Bimmune population. This “immune-enriched” group appears to have a worse prognosis and could have a potential predictive value for response to immunotherapy, justifying the confirmation of these results in a cohort of metastatic pRCC treated with CPI and incombination with targeted therapies
Streszczenia konferencji na temat "MCP-Counter"
Matsuoka, Kodai, Shigeki Hirose, Toru Iijima, Kenji Inami, Yuji Kato, Yosuke Maeda, Ryo Mizuno, Yutaro Sato i Kazuhito Suzuki. "Performance of the MCP-PMT for the Belle II TOP counter". W International Conference on New Photo-detectors. Trieste, Italy: Sissa Medialab, 2016. http://dx.doi.org/10.22323/1.252.0028.
Pełny tekst źródłaCho, Doo Jin, i G. Michael Morris. "Dead-time effects in curved-channel microchannel plates". W OSA Annual Meeting. Washington, D.C.: Optica Publishing Group, 1989. http://dx.doi.org/10.1364/oam.1989.wq4.
Pełny tekst źródłaYONEKURA, Takuya. "Performance of the MCP-PMTs for the TOP counter in the Belle II experiment". W Technology and Instrumentation in Particle Physics 2014. Trieste, Italy: Sissa Medialab, 2015. http://dx.doi.org/10.22323/1.213.0082.
Pełny tekst źródłaMatsuoka, Kodai. "Performance of the MCP-PMTs of the TOP Counter in the First Beam Operation of the Belle II Experiment". W Proceedings of the 5th International Workshop on New Photon-Detectors (PD18). Journal of the Physical Society of Japan, 2019. http://dx.doi.org/10.7566/jpscp.27.011020.
Pełny tekst źródła